Table 2.
Changes | Group 1 Control mice |
Group 2 Cisplatin-induced CKD group |
Group 3 Cisplatin-induced CKD mice group receiving L. fermentum probiotic bacteria |
Group 4 Cisplatin-induced CKD mice group receiving L. fermentum postbiotic |
---|---|---|---|---|
Glomerular atrophy | No noticeable change | No noticeable change | No noticeable change | No noticeable change |
Tubular atrophy | No noticeable change | 19% | 13% | 1% |
Interstitial nephritis | No noticeablechange | 10% | 10% | 1% |
Vascular changes | No noticeable change | No noticeable change | No noticeable change | No noticeable change |